Pharma

Your Article Summary

See Latest Articles

Zila Reports Fiscal 2009 Third Quarter Financial Results
Zila, 06/10/09

The Company has stated that in order to continue as an on-going business and avoid bankruptcy, it will require additional funds to restructure or retire its Senior Secured Convertible Notes due in July 2010, and to grow its business. Efforts to seek additional funding have included discussions with several potential financial and strategic investors, as well as with the holders of the Senior Secured Convertible Notes.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Ultrasound, nuc med on the upswing
Canadian Healthcare Technology, 10/16/09

Explaining Innovation
PharmExec, 10/16/09

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

See All of Financial Reports